Patient data, prescriber data, and distributor and supplier data drive the market. What works in one market may not work in another. Many organizations have a high volume of data gathered across the value chain. On average, 45–50% of the available data is utilized by a healthcare company for decision-making. SG Analytics (SGA) provides assistance with data cleansing, data management, and preparation of insightful dashboards using our proprietary ML tools. These tools support the client in strategic market access, market-entry, competitive intelligence (CI), drug forecasting, and more. SGA's network of 700+ key opinion leaders across different geography equips clients with faster and more effective solutions. SG Analytics' healthcare research & analytics services have been supporting the products and services companies in healthcare for over a decade.
Customization is fundamental to success in today’s digitized and competitive world. With SGA's healthcare market research & consulting services, we help our industry partners with white-labeled research, data management, data analysis, and data convergence around new healthcare market access, CI, HEOR, conference coverage, pharma, and medical device product market entry, along with healthcare investments across developed as well as developing markets.
SGA’s healthcare data insights team conducts and tracks surveys, administrative and medical records, claims data, critical records, surveillance, disease registries, and peer-reviewed literature for data service providers across the globe. Our services are available as daily, weekly, and monthly reports and dashboards that are user-friendly as well as customizable.
Why SGA
Industry leaders
SGA thrives by its brand promise, 'Life's Possible', and is recognized as the UK's most trusted HRA healthcare research and analytics company.
12+ languages
Language capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English experts US/UK.
Data-driven insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-to-end solutioning
The in-house key opinion leader KOL capability of more than 700, along with analytical and ML/AI capabilities, helps in presenting credible competitive information.
White Papers
Market Entry in 2023: Why Must You Also Look at Markets...
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
White Papers
The Blue Ocean Strategy in the Pharmaceutical Industry:...
Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....
White Papers
What Happens When You Invest in Healthcare Consulting and...
Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...
We strongly believe in women power. Our research team consists of more females than males, i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates and MBAs.
Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high-quality, white-labeled research coverage.
